Dr Josie Golding | Lead
Wellcome Trust | United Kingdom

Dr Josie Golding, Lead, Wellcome Trust

Josie Golding is part of the Vaccine Priority Are at Wellcome, an initiative established in 2017. She leads on epidemic preparedness and response across Wellcome, which involves bringing together basic sciences, product development, social sciences, public engagement and policy, to generate more integrated programmes of work. Josie has helped develop the DFID-Wellcome Joint Initiative on Epidemic Preparedness and Response, established in 2018, focusing on generating evidence to inform policy. Prior to joining the Vaccines team, Josie coordinated Wellcome’s response to Zika and yellow fever outbreaks, which was led by the Infection and Immunology Science funding team, where Wellcome funded a large programme of work together with our funding partners UK MRC and UK DFID. Josie’s background is primarily in infectious diseases, host immunity and clinical research both in human and animals. Josie has over 15 years of experience working across a range of specialties. She worked at Public Health England (previously known as the Health Protection agency) working in the Enteric Virus Unit on norovirus and polio virus, and at the Pirbright Institute on veterinary pathogens including African Swine fever and Rinderpest, with the overall goal to increase the knowledge base of infectious diseases. Prior moving to Wellcome, she was based at King’s College London, focusing on cancer immunotherapies to improve patient response to therapies. She has a MSc on molecular biology of infectious diseases from London School of Hygiene and Tropical Medicine, and a PhD in virology and innate immunity from St George’s, University of London.


Oct 29th Day 1 @ 08:40

Paradigm shift in vaccine funding capacity and collaborations for disease X and persistent epidemics

  • How are we incentivizing vaccine development?
  • How will these vaccines reach the LMICs and developing countries?
  • CEPI’s strategy and investment to advance medical countermeasures to emerging diseases
  • The potential of translational medicine and access for all
  • How to secure public funding to advance research and vaccine development
last published: 19/Sep/19 13:06 GMT

back to speakers

Sign Up for Event Updates